XML 48 R42.htm IDEA: XBRL DOCUMENT v3.24.3

Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of the impact of stock-based compensation expense

The Company recorded stock-based compensation expense as follows in the unaudited condensed consolidated statements of income and comprehensive income (in millions):

		Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Stock options		$	0.5			$	0.4			$	1.4			$	1.2
Restricted stock units			4.8				4.2				13.4				11.7
Employee Stock Purchase Plan			0.4				0.2				0.8				0.6
Total stock-based compensation expense		$	5.7			$	4.8			$	15.6			$	13.5

		Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Cost of product revenue		$	0.5			$	0.4			$	1.3			$	1.1
Selling, general and administrative			4.4				3.9				12.4				11.0
Research and development			0.8				0.5				1.9				1.4
Total stock-based compensation expense		$	5.7			$	4.8			$	15.6			$	13.5

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration